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CHAPTER fIfTEEN

Division of Nephrology
MICHAEL

L.

SIMENHOFF, M.D.

((It is no exaggeration to say that the
composition of the blood is determined
not by what the mouth takes in but by
what the kidneys keep.))
W.
-HOMER

Early Nephrology at Jefferson

dialysis had been performed a few times in the
it was not an established procedure for use
in acute renal failure.
Dr. Clark (Figure 15-1), together with Dr. John
Y. Templeton III, (Jefferson, 194-1), explored the
use of isolated intestinal loops as an alternative
functioning membrane to rid the body of uremic
toxins, fluid, and electrolytes. A generous grant
was obtained from the John A. Hartford
Foundation for this study, and Dr. Miles H.
Sigler, Associate Professor of Medicine, became
involved in the kinetics of sodium and glucose
transport across the intestinal membrane. Dr.
Herbert E. Cohn (Jefferson, 1955), Associate
Professor of Surgery, perfected the surgical
techniques for creating the isolated small intestinal
loops in man and continued the study. It soon
became clear, however, that the intestinal mucosa
was much too discriminating a barrier for dialysis.
Uremic toxins other than urea and sodium could
not be removed adequately, and uremic patients
with loops came to need hemodialysis as much as
patients without loops. In order to keep loop
patients well enough to permit studies, a chronic

1950S,

Nephrology has been relatively a latecomer to the
disciplines of medicine as a whole. The major
impetus came from the development of an
artificial kidney by William Kolff, M.D., in
Holland during World War II. This advance in
turn derived from a series of technological steps,
the first of which was the use by Abel, Rountree,
and Turner in 1913 of hemodialysis to remove urea
in dogs. The organization of Nephrology into a
separate Division of the Department of Medicine
began at Jefferson only in 1962 when Laurence G.
Wesson, Jr., was appointed Professor of Medicine
and Head of the Division of Nephrology. Before
this, in the late 1950S and early 1960S, Dr. Janles
E. Clark (Jefferson, 1952) had acquired an artificial
kidney for hemodialysis in order to study adrenal
problems, but this machine was soon COlnmandeered to treat iU patients with acute renal failure.
He held together the loose discipline of renology
alone with the services of a small supplementary
laboratory adjacent to the room that housed the
artificial "kidney unit." Although peritoneal

SMITH (1895-1962)
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dialysis unit had to be created within the Hartford
Foundation research program. Just as one research
program had led to the establishment of the earlier
acute dialysis unit, so another research program
now led to the creation of a chronic dialysis unit.
Dr. Wesson (Figure 15-2) had been recruited
from the New York University Graduate School of
Medicine. He had spent 15 years in close
collaboration with Dr. Homer Smith, one of the
pioneers of Physiological Nephrology, and himself
had been instrumental in developing the concept
of osmolar and free water clearance by the kidney.
There was much enthusiasm in the arrival of Dr.
Wesson to develop a superior nephrology
program, particularly with the presence of the
Clinical Research Center as well as available space
and funds. Dr. Joseph Letteri was appointed
Research Fellow in Medicine in January of 1962 to
further this project.
Dr. Clark continued as the major renal clinician
and gradually dissociated himself from his previous
private partnership practice because of the time
commitments to the nephrology program. He was
supported by the dialyzer and research funds to

FIG. [5-1. James E. Clark, M.D., a pioneer at Jefferson in
clinical nephrology and hemodialysis in the late I950S.

obtain a technician. No one at Jefferson had
special training or extensive experience related to
renal problems beyond that of a general internist
except Dr. F.W. Sunderman, Sr., who headed a
small unit recognized as a chemical section but not
a Division of Medicine. He was often asked to
consult on electrolyte, water, and acid-base
problems. There was no teaching program,
resident rotation, or student elective featuring the
kidney as a discipline until Dr. Michael Simenhoff
joined the Division in 1964. Simenhoff was
recruited from Dr. John Merrill's program at the
Peter Bent Brigham Hospital. As Assistant

FIG. [5-2. Laurence G. Wesson, )f., M.D., Professor of
Medicine and First Head of the Nephrology Division
([9 62).
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• Refinement of Dialysis Technology

Director of the Clinical Research Center, he
developed investigative studies in the diurnal
rhythm of kidney function with Dr. Wesson. The
Division was initially Renal Diseases in Fluid and
Electrolyte Metabolism, next changed to Renal
Disease, and finally to Nephrology in 1966.
It is germane to put nephrology in perspective
in Philadelphia in 1962 when the Division of
Nephrology at Jefferson was initiated. Clinical
nephrology was still part of General Internal
Medicine. Kidney-related research at the
University of Pennsylvania was mainly out of Dr.
Russell Elkinton's chemical section, where Dr.
Miles Sigler took a research fellowship. Dr. Lewis
W. BluemJe, Jr., destined to become the President
of Thomas Jefferson University in 1977, was an
outstanding pioneer in nephrology at the
University of Pennsylvania from 1946 to 1968,
during which time he authored or coauthored 46
articles in this field. Hahnemann Medical College
had a renology section headed by Dr. Albert N.
Brest, who subsequently came to Jefferson as
Director of Cardiology. Neither Woman's Medical
CoUege (later Medical College of Pennsylvania)
nor Temple Medical School had anything going in
tl1e line of nephrology. This paucity of nephrology
services in the early 1960s soon changed, and
nephrology as a subspecialty deVeloped rapidly in
many of the community as well as university
hospitals.
At this time, there was an institutional move to
obtain a general clinical research center for
Jefferson. A committee of Drs. Wise, Sodeman,
Gibbon, and Cantarow directed this effort but
could find no candidate for Director. Because of
Dr. Wesson's reputation he was urged to accept
the position in addition to his responsibilities as
Director of tl1e Division of Nephrology.
.'\round 1964, Dr. Herbert Cohn became
interested in renal transplantation, and a few were
performed, but there was no major institutional
commitment in this area. Later, in 1972, Dr. Harry
Goldsmith, Chairman of the Department of
Surgery, recruited Dr. James Colberg as Chief of
the surgical arm of the transplantation program.

With the departure of Dr. Clark in 1968 to
become the Chief of Medicine at Crozer Chester
Hospital, Dr. Norman Lasker came to Jefferson in
1969 as Director of the Dialysis Unit. Dr. Lasker
continued the development and expansion of the
Unit and introduced new dialysis technologies and
services, particularly in me area of peritoneal
dialysis. Together with Dr. Bruce E. Jarrell
(Jefferson, 1973), a peritoneal dialysis cycler was
developed. Patients could thus be dialyzed while
they were sleeping at night with an automated
system. In 1971 the Clinical Research Center was
discontinued, and many of the clinical investigative
programs carried out in the Center had to be
abandoned. In 1971, Dr. James F. Burke, Jr.
(Jefferson, 1966) (Figure 15-3) was appointed to
the faculty to assist Dr. Lasker in the dialysis
program. In 1973 tl1e Tsaltas dialysis unit with six
beds was established, which was responsible for
approximately 2,000 dialyses per year. Dr.
Theodore Tsaltas, who was Professor of Pathology
at Jefferson, had been a patient on chronic dialysis
and the Center was nan1ed in his honor.

The Early Renal Transplantation
Program
At this time, Dr. James E. Colberg was appointed
to head me surgical arm of the transplant
program. Dr. Steven Bulova was also appointed to
run me tissue typing laboratory and perform me
mixed lymphocyte cultures, procedures mat were
men important in selecting donors for renal
transplantation. In those years approximately ten
transplants were performed per year.
Prior to Dr. Lasker's coming, in me late 1960s
an electron microscopy unit was set up wim Dr.
Serge W. Duckett in neuropathology. Soon after,
Dr. Rum P. Gottlieb, a pediatric nephrologist in
me Department of Pediatrics and active in the
nephrology programs, established a fluorescent
microscopy laboratory so mat these techniques
could be used to detect antibody deposition in
renal tissues. Thus at mis time renal biopsy
services incorporated light, electron, and
fluorescent microscopical analysis, and wide-range
diagnostic services became available.
In 1973 to 1974, while Dr. Michael Simenhoff
was on sabbatical leave in London studying amine

Division ofNephrology • 359

metabolism in uremia at the laboratories of Dr.
Malcome Milne at Westminister Hospital Medical
School in the University of London, Dr. Laurence
Wesson decided to resign his position as Director.
On his return, Dr. Simenhoff as made Acting
Director, and Director in July 1975. At this time
Dr. Anatole Besarab joined the Division with a
secondary appointment in the Department of
Physiology. Dr. Besarab had been trained under
Dr. Franklin Epstein, an internationally known
nephrologist at Harvard Medical School, where
Dr. Besarab had learned the technique of
perfusing isolated rat kidney. under variou~ .
physiological and pathophysIOlogICal conditions.
Dr. Besarab's expertise, together with Dr.
.
Wesson's background in this area, led to National
Institutes of Health funding. Dr. Besarab studied
the interrelationship of calcium, parathyroid
hormone, and cyclic AMP, and also made
contributions in the better understanding of
transplantation nephropathy. This, combined with
Dr. SimenhofPs funding for the production of
carcinogenic nitrosamines in patients with chronic
renal failure, also now funded by NIH, and Dr.
Wesson's continued Career Award from the
National Institutes of Health, gave the Division a
solid base of support for basic research in the
Division. Dr. Wesson continued his research
studies on the preservation methods of the isolated
kidney.

FIG. 15-3. James F. Burke, Jr., M.D., Professor of
Medicine; nephrologist for renal transplantation program.

• Growth of Renal Transplantation
The transplantation program accelerated with the
recmitment of Dr. Bruce E. Jarrell in 1980. Dr.
Jarrell's background in engineering had already
facilitated contributions to the developmem of the
cycling peritoneal dialysis machine pr~viously
mentioned, and his ability and enthusiasm gave
new life to what had been a stagnant transplantation program. With Dr. James Burke as the
nephrology arm of the program ~nd Dr. Jarrell on
the surgical side, the transplantation prog:am grew
vigorously, with physici.an referrals sta~ewlde and
from nonaffiliated hospitals. With partiCIpation of
Dr. Besarab many clinical studies were performed
in the transplantation field, and at the basic level
Dr. Jarrell was funded for studies on the role of
the endothelial cell in transplantation rejection.
The nwnber of transplants per year rose to 80.
As the clinical services continued to grow in the
1980s it became essential to recmit additional
personnel. Dr. Norman La~ker bad left Jefferson
in 1979 to take up an appomtment as head of the
Division of Nephrology at the New Jersey College
of Medicine in Newark. Dr. Burke became head
of the Dialysis Unit, but with the growing
transplantation progr~, it b~c~e c1~ear that the
Division needed a fuU-tlIne dialySIS director apart
..
from the transplantation group.
Dr. Nancy B. Jcrmanovich was recnuted m July
of 1982 to bolster the clinical services but mainly
to develop a program in experimental
glomerulonephritis, an area that had no.t been
previously developed. With the emphaSIS on ,
dialysis and with more than 60 percent of pa.nents
on chronic dialysis (having glomerulonephritis as
the etiology of the renal disease), it w~s. felt that
this was an important area for the DIvISion to
develop. Dr. Jermanovich came from New York
State University at Syracuse and had been, tramed
by Dr. Willianl Couser at Boston UI1IVerslty
during her fellowship. Arrangme,nts ha~ been
made with the Department of BIOchemistry. to
interdigitate her interests in immunology With
those of the Deparunent of Biochemistry.
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Soon after this, Dr. George C. Francos
(Jefferson, 1978), who had come through the
Jefferson ranks, including a Fellowship, was
appointed to the Division and to be the Director
of the chronic dialysis program. The dialysis
program was still growing, and the facilities at the
Health Science Building on Ninth and Sansom
Streets containing 12 stations for three daily shifts
had already become cramped. Both hemodialysis
and peritoneal dialysis modalities were offered,
with emphasis on in-Center hemodialysis and
continuous ambulatory peritoneal dialysis (CAPD).

The history of the nephrology programs at the
affiliated hospitals was one of gradual
independence, so that each of them acquired
free-standing independent nephrology units.
Earlier, intermittent involvement at Jefferson by
Dr. Miles Sigler (Lankenau Hospital), Dr. John T.
Magee (Jefferson, 1957; Bryn Mawr Hospital), Dr.
Robert B. Flinn (Wilmington Medical Center),
and Dr. John P. Capelli (Jefferson, 1962; Our
Lady of Lourdes Hospital) had resulted in
independent units of high caliber. This was
benefIcial in the teaching of Jefferson medical
students and house officers when they rotated
through these affiliated hospitals. The affiliated
nephrology programs became important sources
for transplantation referral.
Progress in the prevention and treatment of
renal diseases has not only saved lives but
provided a normal life span for many of its
unfortunate victims.
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CHAPTER SIXTEEN

Division of Medical
Oncology
WILLIAM

E.

DELANEY, M.D.

((While there are several chronic diseases
more destructive to life than cancer,
none is more feared.J)
H.
(l865-1939)
-CHARLES

1:rHOUGH medical oncology was first
officially recognized as a medical
subspecialty by the American Board of
Internal Medicine in 1972, a formal Division of
Medical Oncology in the Department of Medicine
at Jefferson had been established since 1961. The
first Director (1961-1970) was Arthur Weiss, M.D.
(Figure 16-1), and the second (1970-1980) was
Chester Southam, M.D. (Figure 16-2). Acting
Directors were William E. Delaney, M.D.
(Jefferson, 1953; 1980-1981) and J. Frederick
Laucius, M.D. (Jefferson, 1967; 1981-1984-). The
third Director is Michael J. Mastrangelo, M.D.,
appointed in 1984-.
The major activities of the Division since its
inception have been patient care, teaching,
research, and the training of medical oncology
Fellows. Among the latter, the first Fellows were
Laird Jackson, M.D., who was the first National
Institutes of Health Postdoctoral Fellow (19611962), and Harvey Brodovsky, M.D. (1961-1963).
Several additional Fellows have served in the

A

MAYO

Division since that time, most notably Carla
Goepp, M.D. (Figure 16-3), (1965-1967), who
became Associate Dean of Student Affairs and
Director of the Office of Student Counseling and
Career Planning, and Michael J. Mastrangelo,
M. D. (1968- 1970). Significant accomplishments in
cancer care, research, and teaching at Jefferson
occurred in the years before the establislunent of
the Division.

The Tumor Clinic and Elizabeth
Storck I(raemer Foundation
The Tumor Clinic was informally begun in 1928
and has continued since that date as the major
institutional follow-up mechanism for cancer
patients. Formal establishment began in the fall of
1929 when, through the auspices of William H.
Kraemer, M.D. (Figure 10-4-, Jefferson, 1906),
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